SEC Filing Summary: Alphabet Inc. Form 13F
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Alphabet Inc. for the reporting period ending March 31, 2019. The document discloses the equity securities held by the company at the end of the quarter. It does not contain Alphabet's own financial performance data (revenue, profit, etc.) but rather details its investment portfolio in other public companies.
Key Financial Metrics and Portfolio Holdings
The filing lists specific equity positions held by Alphabet. The table below summarizes the reported holdings by issuer, including share counts and total value (in thousands of USD).
| Issuer | Security Class | Shares Held | Value ($000s) | Voting Authority |
|---|---|---|---|---|
| JD.com Inc | SPON ADR CL A | 408,637 | 13,553,474 | Sole |
| Lyft Inc | CL A COM | 1,004,380 | 12,828,964 | Shared/Sole |
| Arris Intl Inc | SHS | 240,347 | 7,603,500 | Sole |
| Arcus Biosciences Inc | COM | 63,072 | 5,049,786 | Sole |
| Magenta Therapeutics Inc | COM | 54,996 | 3,339,138 | Sole |
| Snap Inc | CL A | 28,856 | 2,618,548 | Sole |
| Forty Seven Inc | COM | 24,983 | 1,545,966 | Sole |
| Alector Inc | COM | 21,987 | 1,174,540 | Sole |
| Spero Therapeutics Inc | COM | 14,251 | 1,112,473 | Sole |
| Evelo Biosciences Inc | COM | 8,484 | 1,060,495 | Sole |
| Gritstone Oncology Inc | COM | 12,356 | 929,022 | Sole |
| Autolus Therapeutics PLC | SPON ADS | 22,472 | 714,072 | Sole |
| Cloudera Inc | COM | 4,679 | 427,710 | Sole |
| DocuSign Inc | COM | 21,307 | 411,009 | Sole/Shared |
| Dexcom Inc | COM | 3,289 | 110,457 | Sole |
| Dropbox Inc | CL A | 284 | 13,033 | Sole |
| Square Inc | CL A | 925 | 12,342 | Sole |
Note: Values for Lyft and DocuSign are aggregated from multiple line items in the source text. The filing does not provide Alphabet's total revenue, profit, cash flow, or debt levels.
Material Changes and Portfolio Composition
This filing represents a snapshot of holdings as of March 31, 2019. The portfolio is heavily concentrated in technology and biotechnology sectors. Notable characteristics include:
- Top Holdings: JD.com and Lyft represent the largest disclosed positions by value, exceeding $12.8 million and $13.5 million respectively.
- Biotech Exposure: Significant investments in early-stage or growth biotech firms including Arcus, Magenta, Spero, and Gritstone.
- Voting Authority: Most positions are held with "Sole" voting authority, though some (e.g., Lyft, DocuSign) show "Shared" or mixed authority.
Guidance, Risks, and Contingencies
The filing text does not contain management commentary, forward-looking guidance, or specific risk factors regarding Alphabet's operations. It is a regulatory disclosure of securities ownership. The standard SEC disclaimer applies: the Commission has not reviewed the information for accuracy or completeness.
Key Facts for Investor Verification
- Portfolio Concentration: Verify if the disclosed positions represent the entirety of Alphabet's venture capital or strategic equity portfolio or only a subset meeting reporting thresholds.
- Valuation Timing: Confirm that the values listed reflect market prices as of March 31, 2019, and have not been adjusted for subsequent market movements.
- Ownership Structure: Investigate the distinction between "Sole" and "Shared" voting authority for positions like Lyft and DocuSign to understand control dynamics.
- Missing Financials: Acknowledge that this document provides no data on Alphabet's core business performance (Search, Cloud, YouTube) for the period.